Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA accepts to review Sanofi’s multiple myeloma candidate isatuximab
Image: FDA has set a target action date of 30 April 2020 to take a decision on isatuximab. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.
Image: FDA has set a target action date of 30 April 2020 to take a decision on isatuximab. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.